BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17188341)

  • 1. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
    Song SH; Lee JK; Seok OS; Saw HS
    Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
    Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
    Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.
    Xi L; Wang S; Wang C; Xu Q; Li P; Tian X; Wu P; Wang W; Deng D; Zhou J; Ma D
    Oncol Rep; 2009 Jan; 21(1):25-31. PubMed ID: 19082439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between human papillomavirus (HPV) type 16 infection and E6/E7 gene variant and the cervical lesions in Beijing].
    Yang YJ; Zhao J; Liao QP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):32-4. PubMed ID: 17429529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies of using real-time fluorescence quantitative PCR and RT-PCR to detect E6 and E7 genes of human papillomavirus type 16 in cervical carcinoma cell lines].
    Chen YY; Peng ZL; Liu SL; He B; Hu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):443-6. PubMed ID: 17593827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
    Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
    J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
    Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
    Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96.
    Wadler S; Levy D; Frederickson HL; Falkson CI; Wang Y; Weller E; Burk R; Ho G; Kadish AS;
    Gynecol Oncol; 2004 Mar; 92(3):957-64. PubMed ID: 14984966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.
    Molden T; Kraus I; Karlsen F; Skomedal H; Hagmar B
    Gynecol Oncol; 2006 Jan; 100(1):95-100. PubMed ID: 16153696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction.
    Rose BR; Thompson CH; Tattersall MH; Elliott PM; Dalrymple C; Cossart YE
    Gynecol Oncol; 1995 Feb; 56(2):239-44. PubMed ID: 7896192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response.
    Lee KA; Cho KJ; Kim SH; Shim JH; Lim JS; Cho DH; Song MS; Dinarello CA; Yoon DY
    Cancer Lett; 2005 Nov; 229(2):261-70. PubMed ID: 16125299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology.
    Salit IE; Tinmouth J; Chong S; Raboud J; Diong C; Su D; Sano M; Lytwyn A; Chapman W; Mahony J
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1986-92. PubMed ID: 19567510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.